Bonesupport Holding AB (publ) (2B4.F)
EUR 28.6
(2.14%)
EUR 28.6
(2.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 245.02 Million SEK | 460.21% |
| 2022 | -6.08 Million SEK | 26.58% |
| 2021 | -8.28 Million SEK | 17.91% |
| 2020 | -10.09 Million SEK | 34.16% |
| 2019 | -15.32 Million EUR | 11.94% |
| 2018 | -17.4 Million EUR | -32.79% |
| 2017 | -13.1 Million EUR | -13.98% |
| 2016 | -11.49 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 27.42 Million EUR | 25.55% |
| 2024 Q3 | 30.56 Million SEK | 11.46% |
| 2024 Q1 | 1.89 Million SEK | 103.51% |
| 2023 FY | 21.91 Million SEK | 460.21% |
| 2023 Q4 | 959.86 Thousand SEK | -95.14% |
| 2023 Q1 | 27.25 Thousand SEK | 101.49% |
| 2023 Q2 | 440.7 Thousand SEK | 1517.1% |
| 2023 Q3 | 19.73 Million SEK | 4378.5% |
| 2022 Q2 | -1.51 Million EUR | 3.58% |
| 2022 FY | -6.08 Million SEK | 26.58% |
| 2022 Q4 | -1.83 Million EUR | -33.87% |
| 2022 Q3 | -1.36 Million EUR | 9.66% |
| 2022 Q1 | -1.57 Million EUR | 32.97% |
| 2021 Q4 | -2.34 Million EUR | 0.0% |
| 2021 FY | -8.28 Million SEK | 17.91% |
| 2020 FY | -10.09 Million SEK | 34.16% |
| 2019 FY | -15.32 Million EUR | 11.94% |
| 2018 FY | -17.4 Million EUR | -32.79% |
| 2017 FY | -13.1 Million EUR | -13.98% |
| 2016 FY | -11.49 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 151.84 Million EUR | -61.366% |
| Carl Zeiss Meditec AG | 290.39 Million EUR | 15.625% |
| Fielmann Aktiengesellschaft | 127.64 Million EUR | -91.957% |
| Gerresheimer AG | 116.12 Million EUR | -110.996% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | -19.406% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | -19.406% |